SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Michel FB. Specific immunotherapy in asthma: is it effective J Allergy Clin Immunol 1994;94:111.
  • 2
    Dreborg S, Mosbech H, Weeke B. Immunotherapy and bronchial asthma. In: KayAB, editor. Clinical immunology and allergy. The allergic basis of asthma. London : Baillière Tindall, 1988.
  • 3
    Immunotherapy Subcommittee, EAACI. Immunotherapy. Position paper. Allergy 1988;43 Suppl 6.
  • 4
    Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79:6607.
  • 5
    Committee on Safety of Medicines. Desensitizing vaccines. BMJ 1986;293:94852.
  • 6
    Bousquet J, Michel FB. Specific immunotherapy, past, present and future. Allergologie 1989;12:1937.
  • 7
    Norman PS. Immunotherapy. In: MelilloG, NormanPS, MaroneE, editors. Respiratory allergy. Toronto : BC Decker, 1990:315.
  • 8
    Bousquet J, Maasch HJ, Martinet B, et al. Double-blind, placebo-controlled, immunotherapy with mixed grass-pollen allergoid. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:43946.
  • 9
    Turkelataub PC, Rastogi SC, Baer H, et al. A standardized quantitative skin-test assay of allergen potency and stability studies on the allergen dose response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982;70:34352.
  • 10
    van Metre, T Jr, Adkinson, NF Jr. Immunotherapy for aeroallergen disease. In: Middleton, EJr, Reed, CE, EllisEF, AdkinsonNFJr, YungingerJW, editors. Allergy, principles and practice. Vol. II. St Louis , MO : CV Mosby, 1988:132744.
  • 11
    Plans-Mills TAE, Thomas WR, Aalberse RC, Vervloet D, Chapman MD. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol 1992;89:104660.
  • 12
    Turkeltaub PC. The importance of allergen dose on the safety and efficacy of immunotherapy of ragweed hay fever with standardized short ragweed extracts [Abstract]. J Allergy Clin Immunol 1986;77(part 2):211.
  • 13
    Basomba A. The importance of allergen dosage and treatment schedules in immunotherapy. XII International Congress of Allergology and Clinical Immunology, Washington, DC, 1985.
  • 14
    Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Asthma Education Program, Expert Panel Report. J Allergy Clin Immunol 1991;88:425534.
  • 15
    Brighton WD, Topping MD, Henocq E. Activity units for allergen extracts. Clin Allergy J 979:9:5916.
  • 16
    Lombardero M, Gonzalez C, Duffort O, et al. Evaluatión de la actividad biológica total y compositión alergénica de los extractos alergénicos. Allergol Immunopathol (Madr) 1986; 14:189.
  • 17
    Ventas P, Lombardero M, Duffort O, Carreira J. Cuantificación de los alergenos Der p I y Der f I de los ácaros y Fel d I de gato mediante un ELISA en fase sólida. Rev Esp Alergol Inmunol Clin 1990;5:715.
  • 18
    Aas K. Heterogeneity of bronchial asthma. Allergy 1981; 36:314.
  • 19
    Finney DJ. Statistical methods in biological assay. 3th ed. London : Charles Griffin, 1978:69104.
  • 20
    Dreborg S. Immunotherapy today and future demands on clinical investigations. Second Nordic Research Symposium Regarding Immunological and Pharmacological Mechanisms in Allergy/Nonallergy. University of Copenhagen, 1984:3840.
  • 21
    Dreborg S. Skin tests used in type I allergy testing. Allergy 1989;44 Suppl 10:408.
  • 22
    Möller CH, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984:39:3741.
  • 23
    Sanchez-Madrid F, Morago G, Corbi A, Carreira J. Monoclonal antibodies to three distinct epitopes on human IgE: their use for determination of allergen-specific IgE. J Immunol Methods 1984;73:36778.
  • 24
    Jimeno L, Carreira J, Lombardero M. Obtention of monoclonal antibodies against human IgG4 using two different immunization strategies: development of a biotin-based ELISA for Der p I quantitation. Int Arch Allergy Appl Immunol 1990;92:17582.
  • 25
    Moscoso J, Jimeno L, Obispo T, Carreira J. Monoclonal antibodies against human IgE. Identification of an epitope sharing properties with the high affinity receptor binding site. Mol Immunol 1991;55:13446.
  • 26
    Morago G, Carreira J, Corbi A, Sánchez Madrid F. Preparation de anticuerpos monoclonales frente a la IgG e IgE humanas y su utilizatión como reactivos en el diagnóstico de enfermedades alérgicas. Inmunología 1985;4:11118.
  • 27
    Jimeno L, Serrano C, Moscoso J, Carreira J. An ELISA for the quantification of allergen specific IgG4 antibodies. Int Arch Allergy Appl Immunol 1992;94:12075.
  • 28
    Mosbech H, Lind P. Collection of house dust for analysis of mite allergens. Allergy 1986;41:3738.
  • 29
    Barber D, Chamorro MJ, Carpizo JA, et al. Valoración de la presión alergénica ambiental. Interés de esta determinatión en la preventión, diagnóstico y tratamiento de las enfermedades alérgicas. Rev Esp Alergol Inmunol Clin 1990:5:12532.
  • 30
    Tabar, Al, García, BE, Rodriguez A, Olaguibel JM, Muro MD, Quirce S. A prospective safety monitoring study of immunotherapy with biologically standardized extracts. Allergy 1993;48:4503.
  • 31
    Mosbech H, Dirksen A, Dreborg S, et al. Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. IV. Occurrence and prediction of side effects. Allergy 1990;45:14250.
  • 32
    D'Souza MF, Pepys J, Wells ID, et al. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects. Clin Allergy 1973;3:17793.
  • 33
    Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990; 85:4739.
  • 34
    Wahn U, Schweter C, Lind P, Løwenstein H. Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. J Allergy Clin Immunol 1988;82:36070.
  • 35
    Mosbech H, Dreborg S, Frølund L, et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extracts. I. Clinical effect evaluated by diary cards and a retrospective assessment. Allergy 1989;44:48798.
  • 36
    Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 1988;18:5018.
  • 37
    Juniper EF, O'Connor J, Roberts RS, Evans S, Hargreave FE, Dolovich J. Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens. J Allergy Clin Immunol 1986;78:8516.
  • 38
    Mailing H-J, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum, Allergy 1986;41:50719.
  • 39
    Platts-Mills TAE, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol 1987;80:75575.
  • 40
    Dreborg S, Mosbech H, Weeke B. Immunotherapy and bronchial asthma. In: KayAB, editor. Clinical immunology and allergy. The allergic basis of asthma. London : Baillière Tindall, 1988.
  • 41
    Durham SR, Varney V, Gaga M, Frew AJ, Jacobson M, Kay AB. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21 Suppl 1:20610.
  • 42
    Mosbech H, Djurup R, Dreborg S, et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extracts. III. Effect on mite-specific immunological parameters and correlation to changes in mite-sensitivity and symptoms. Allergy 1990;45:13041.
  • 43
    Einarsson R, Dreborg S, Hammarström L, et al. Monitoring of mite Dermatophagoides farinae allergen. Specific IgG and IgG subclass distribution in patients on immunotherapy. Allergy 1992;47:7682.
  • 44
    Nakagawa T. IgG subclass changes in response to desensitisation. Monogr Allergy 1986;19:25361.
  • 45
    Aalberse RC, Gaag R, Leuwen J. Serologic aspects of IgG4 antibodies. 1. Prolonged immunization results in an lgG4–restricted response. J Immunol 1983:130:7226.
  • 46
    Devey ME, Wilson DV, Wheeler AW. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever during hyposensitization. Clin Allergy 1976;6:22736.
  • 47
    Bousquet J, Calvayrac P, Guerin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:73444.
  • 48
    Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993;91:70922.
  • 49
    Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:86875.
  • 50
    McHugh SM, Ewan PW. A clinical index: a new method to assess efficacy of allergen immunotherapy. Allergy 1992;47:11520.